5/1/2020

speaker
Chantelle
Conference Operator

Good day and welcome to the AdvanceX First Quarter 2020 Earnings Conference Call. Today's conference is being recorded. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star 1 on your telephone keypad. To withdraw your question, please press star 2. I would now like to turn this conference over to Adam Kressel, Director of Investor Relations. Please go ahead.

speaker
Adam Kressel
Director of Investor Relations

Thank you, Chantelle. Good morning and welcome to AdvanceX's first quarter 2020 earnings conference call. With me here today are President and CEO Aaron Kane and Senior Vice President and CFO Michael Preston. This call and webcast, including any non-GAAP reconciliations, are available on our website at investors.advancex.com. Note that elements of this presentation contain forward-looking statements that are based on our best view of the world and and of our business as we see it today. Those elements can change, and the actual results could differ materially from those projected, and we ask that you consider them in that light. We refer you to the forward-looking statements included in our press release and earnings presentation. In addition, we identify the principal risks and uncertainties that affect our performance in our SEC filings, including our annual report on Form 10-K, as further updated in subsequent filings with the SEC. This morning, we'll review our financial results for the first quarter and share our thoughts on the COVID-19 pandemic and outlook for our key product lines and end markets. Finally, we'll leave time for your questions at the end. So with that, I'll turn the call over to Advancix's President and CEO, Erin Kane.

speaker
Aaron Kane
President and Chief Executive Officer

Thanks, Adam, and good morning, everyone. Thank you for joining us and for your continued interest in Advancix. First, I'd like to start off the call by offering our condolences to all who have been affected by the COVID-19 pandemic. I hope that everyone listening today, as well as their families and coworkers, are healthy and staying safe. We are clearly in unprecedented times, and I also want to send my heartfelt thanks and appreciation to our 1,500 teammates at Advancix. This crisis has impacted all of our professional and personal lives in many ways. We have adapted our routines, work schedules, and even how we work. With the challenge, though, comes many opportunities. It has forced our collective organizations to be even more agile, efficient, and creative with our processes while innovating on our strengths along the way. As we highlighted in our March 31st press release, the business of chemistry in our specific industry was designated as essential during the response to COVID-19 for both public health and safety, as well as community well-being. We take our obligations seriously to produce materials that support the broader populations while maintaining a relentless focus on health and safety. At the onset of the crisis, my leadership team began to meet daily as part of our organization's broader tiered accountability meeting structure to ensure we stay aligned on key priorities, identify potential risks and opportunities, and maintain a continuous communications feedback loop throughout the company. Daily communications to the organization highlight areas of focus, as well as the great work being done by our employees each day. I continue to be inspired by the teamwork, collaboration, and nimble decision-making that is happening across the board. Above all, health and safety remains our top priority and core to who we are as we navigate through this environment. Significant efforts and actions have been taken to protect our employees, customers, suppliers, shareholders, and surrounding communities, including de-risking our previously scheduled second quarter planned plant turnaround and shifting a majority of the work into the third quarter. We are very pleased with the results our practices and protocols are delivering. With the significant challenges the world is facing from COVID-19 pandemic, we have restructured our call today to focus on the key information we believe is most important to our shareholders. Mike will briefly review our first quarter results, and then we'll spend most of the call highlighting our response to COVID-19 from a health, safety, and operations perspective, as well as actions we're taking to support our financial position. We'll also dive into what we're seeing from an industry and end market perspective. While we do expect nylon demand weakness to continue particularly in carbon-engineered plastics applications tied to consumer demand, we do see resilience across various other product lines, including our acetone for hand sanitizer and acrylic screens, nylon for food packaging, and granular ammonium sulfate into the heart of the domestic planting season. Our integrated asset base, global low-cost position, and diverse co-product portfolio served us well in the first quarter. And as we progress through the second quarter, we're executing our business continuity plans to ensure we remain a trusted partner for reliable supply to our customers. There is considerable uncertainty regarding the duration of this crisis, the pace of recovery, and the impact it potentially will have on the global economy. The good thing is that advances is starting from a strong foundation. The assets we have, our business model, global cost advantage, and resilience across the organization give us a great base to build upon as we navigate through these dynamics. With that, I'll turn it over to Mike to discuss the details of the quarter.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Investor presentation